Filing Details

Accession Number:
0001209191-23-024390
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-17 06:00:07
Reporting Period:
2023-04-13
Accepted Time:
2023-04-17 06:00:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Oncternal Therapeutics Inc. ONCT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1244823 B James Breitmeyer 12230 El Camino Real, Suite 230
San Diego CA 92130
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-13 100,000 $0.29 146,544 No 4 P Indirect By Family Trust
Common Stock Acquisiton 2023-04-14 47,750 $0.30 194,294 No 4 P Indirect By Family Trust
Common Stock Acquisiton 2023-04-14 2,250 $0.29 196,544 No 4 P Indirect By Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Family Trust
No 4 P Indirect By Family Trust
No 4 P Indirect By Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 541,981 Direct
Common Stock 23,918 Indirect By Spouse
Common Stock 733 Indirect By Child